The panel provides insights on enhancing outcomes for patients with metastatic non-small cell lung cancer without targetable driver mutations.
Mark Socinski, MD
Advertisement
Articles by Mark Socinski, MD
The panel shares clinical practices for overcoming immunotherapy resistance in patients with non-small cell lung cancer.
A panel of experts on non-small cell lung cancer outline factors that impact how well patients respond to immunotherapy.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors
2
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
3
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
4
Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk
5